Next, CD133+ or CD133− cells transfected with Ikaros or control from SMMC-7721 or HCC-LY5 were subcutaneously injected into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. This evidence concerns the gene PROM1 and hepatocellular carcinoma.